Expression of plasminogen activator inhibitor-1 (PAI-1), a key regulator of plasminogen activation, has been shown to be correlated with risk of VTE, especially in pancreatic cancer [30]. This evidence concerns the gene SERPINE1 and pancreatic neoplasm.